Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.600
-0.012 (-1.96%)
At close: Apr 28, 2026, 4:00 PM EDT
0.605
+0.005 (0.78%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Cytosorbents Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Cytosorbents stock have an average target of 5.38, with a low estimate of 0.75 and a high estimate of 10. The average target predicts an increase of 796.67% from the current stock price of 0.60.
Analyst Consensus: Buy
* Price targets were last updated on Mar 26, 2026.
Analyst Ratings
The average analyst rating for Cytosorbents stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,566.67% | Mar 26, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,566.67% | Jan 12, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,566.67% | Dec 16, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,566.67% | Nov 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $1 → $0.75 | Hold | Maintains | $1 → $0.75 | +25.00% | Nov 14, 2025 |
Financial Forecast
Revenue This Year
40.90M
from 37.06M
Increased by 10.34%
Revenue Next Year
50.06M
from 40.90M
Increased by 22.41%
EPS This Year
-0.17
from -0.13
EPS Next Year
-0.06
from -0.17
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 42.8M | 53.6M | |||||
| Avg | 40.9M | 50.1M | |||||
| Low | 38.3M | 46.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 15.6% | 31.0% | |||||
| Avg | 10.3% | 22.4% | |||||
| Low | 3.4% | 12.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.16 | -0.05 | |
| Avg | -0.17 | -0.06 | |
| Low | -0.19 | -0.07 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.